CORI CHASTAIN: Open Payments
NPI 1265143416 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 15 payments from 9 companies in 2025. Trend: 2023 $117 · 2024 $4,030 · 2025 $527
Food & beverage: $427Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $284 |
| Lilly USA, LLC | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Karyopharm Therapeutics Inc. | 1 | $34 |
| SpringWorks Therapeutics, Inc. | 1 | $29 |
| Genentech USA, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Celgene Corporation | 1 | $19 |
| Eisai Inc. | 1 | $18 |
Products named: Vyloy, VERZENIO, XPOVIO, Fabhalta, Polivy, OJJAARA, REBLOZYL, KISQALI.
Industry payments across CA — which companies pay providers there.
